Explore the words cloud of the BactiVax project. It provides you a very rough idea of what is the project "BactiVax" about.
The following table provides information about the project.
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
|Coordinator Country||Ireland [IE]|
|Total cost||4˙009˙372 €|
|EC max contribution||4˙009˙372 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2019-10-01 to 2023-09-30|
Take a look of project's partnership.
|1||UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN||IE (DUBLIN)||coordinator||549˙368.00|
|2||LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN||DE (MUENCHEN)||participant||505˙576.00|
|3||ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS||ES (DERIO VIZCAYA)||participant||501˙809.00|
|4||IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE||UK (LONDON)||participant||303˙172.00|
|5||ST GEORGE'S HOSPITAL MEDICAL SCHOOL||UK (LONDON)||participant||303˙172.00|
|6||THE QUEEN'S UNIVERSITY OF BELFAST||UK (BELFAST)||participant||303˙172.00|
|7||ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE||CH (LAUSANNE)||participant||281˙276.00|
|8||CONSIGLIO NAZIONALE DELLE RICERCHE||IT (ROMA)||participant||261˙499.00|
|9||UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA||IT (MILANO)||participant||261˙499.00|
|11||LIONEX GMBH||DE (BRAUNSCHWEIG)||participant||252˙788.00|
|12||EOTVOS LORAND TUDOMANYEGYETEM||HU (BUDAPEST)||participant||229˙715.00|
BactiVax (anti-Bacterial Innovative Vaccine Training Network) is a European training network (ETN) that will provide high-level training in vaccinology to a new generation of 15 high-achieving, early-stage researchers (ESRs). This innovative ETN uniquely blends cutting-edge research training, non-academic placements and transferable skills. It will develop strong entrepreneurial and creative mindsets. BactiVax will train ESRs in a broad range of transferable skills enabling them to thrive in careers in vaccine research within academia and/or industry through discovery, development, and delivery of innovative therapeutic and prophylactic vaccines. The World Health Organisation has identified antimicrobial resistance (AMR) as one of the three greatest threats to mankind. There is a urgent need to train innovative ESRs in the development of new vaccines against AMR infections. BactiVax will tackle the societal challenge caused by the emergence of AMR pathogens and have significant impact on pathogens causing chronic, life-threatening respiratory and/or systemic infections. BactiVax training will cover critical areas of vaccinology from early antigen discovery to optimisation of host response and delivery of vaccine antigens. It will also encompass the increasing problem of vaccine hesitancy in its public engagement. The specific research objectives are to: 1) Identify novel, protective vaccine antigens against target pathogens; 2) Optimise the host response to vaccines; 3) Optimise vaccine delivery; 4) Lead on vaccine advocacy. BactiVax includes 2 SME beneficiaries, a multinational vaccine company and 4 SMEs as partners all of whom are involved in training, entrepreneurship, commercial vaccine development and vaccine antigen processing. All ESRs will have secondments in non-academic environment to enhance their exposure to the commercial. Overall, BactiVax will provide ESRs with rich experience and advanced multidisciplinary skills in the cutting edge area of vaccines
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTIVAX" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BACTIVAX" are provided by the European Opendata Portal: CORDIS opendata.